Vijay Mohan | Cancer Drug Discovery | Innovative Research Award

Published-on by Indian Scientist

Innovative Research Award

Vijay Mohan
Galgotias University

Vijay Mohan
Affiliation Galgotias University
Country India
Scopus ID 57472028500
Documents 2
Citations 23
h-index 2
Subject Area Cancer Drug Discovery
Event Indian Scientist Awards

Vijay Mohan is associated with Galgotias University, India, and is engaged in research related to Cancer Drug Discovery. His academic work focuses on scientific approaches that contribute to understanding therapeutic targets, drug development strategies, and translational biomedical research. Through scholarly publications and research dissemination, he has contributed to the growing body of knowledge supporting advancements in oncology and pharmaceutical sciences.[1]

Abstract

The Innovative Research Award recognizes researchers who demonstrate originality, scientific rigor, and meaningful scholarly contributions. Vijay Mohan’s research profile reflects engagement in Cancer Drug Discovery, a field that integrates biomedical science, medicinal chemistry, pharmacology, and computational approaches to identify and develop effective therapeutic interventions. His publication and citation record illustrates active participation in scientific inquiry and knowledge dissemination within the biomedical research community.[1][2]

Keywords

Cancer Drug Discovery; Oncology Research; Therapeutic Development; Pharmaceutical Sciences; Biomedical Innovation; Precision Medicine; Drug Design; Translational Research; Cancer Therapeutics; Innovative Research.

Introduction

Cancer remains one of the most significant global health challenges, creating an ongoing need for innovative therapeutic strategies and improved treatment approaches. Cancer Drug Discovery encompasses multidisciplinary efforts directed toward identifying novel compounds, therapeutic targets, and personalized treatment methodologies. Researchers working in this field contribute to advancements that support both fundamental scientific understanding and practical clinical applications.[2]

Research Profile

Vijay Mohan is affiliated with Galgotias University and has established a documented research presence within Cancer Drug Discovery. According to available scholarly indicators, his profile includes two indexed publications, twenty-three citations, and an h-index of two. These metrics reflect research visibility and participation in academic discourse within biomedical and pharmaceutical research domains.[1]

  • Research focus on cancer therapeutics and drug discovery.
  • Interest in translational and biomedical research methodologies.
  • Contribution to scientific publication and scholarly communication.
  • Participation in interdisciplinary healthcare research initiatives.

Research Contributions

Research contributions within Cancer Drug Discovery support the identification of novel therapeutic compounds and improve understanding of disease mechanisms. Scientific efforts in this area often involve target validation, medicinal chemistry, molecular biology, and pharmacological evaluation. Such contributions assist in the development of more effective and personalized treatment strategies for cancer patients.[2]

  • Investigation of therapeutic targets relevant to oncology.
  • Support for innovative approaches to drug development.
  • Contribution to evidence-based biomedical research.
  • Participation in scientific initiatives focused on healthcare advancement.

Publications

The publication record associated with Vijay Mohan reflects scholarly engagement within biomedical and pharmaceutical research. Publications serve as an important mechanism for communicating scientific findings, facilitating peer review, and supporting future investigations in cancer-related research fields.[1]

  1. Research publications related to cancer therapeutics.
  2. Scientific articles supporting drug discovery initiatives.
  3. Peer-reviewed contributions to biomedical literature.
  4. Collaborative research outputs within healthcare sciences.

Research Impact

Research impact may be evaluated through scholarly publications, citations, academic visibility, and contribution to scientific advancement. The citation record associated with Vijay Mohan indicates engagement with the research community and demonstrates that his work has contributed to ongoing scientific discussions within cancer-related biomedical research.[1]

Award Suitability

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate originality, scientific relevance, and meaningful academic contribution. Based on available research indicators and documented scientific engagement, Vijay Mohan exhibits characteristics aligned with innovative research practice through his involvement in Cancer Drug Discovery and biomedical research initiatives. These attributes support consideration within research recognition and excellence programs.[1]

Conclusion

Vijay Mohan’s research profile reflects continued engagement in Cancer Drug Discovery and biomedical research. Through scholarly publication, scientific communication, and contributions to oncology-related investigations, he participates in efforts aimed at advancing therapeutic innovation and healthcare outcomes. The Innovative Research Award provides an appropriate framework for recognizing such scholarly contributions and encouraging continued research excellence.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Vijay Mohan, Author ID 57472028500. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57472028500
  2. Role of Transcription Factor BEND3 and Its Potential Effect on Cancer Progression
    https://www.mdpi.com/2072-6694/15/14/3685

Meghraj Vivekanand Suryawanshi | Pharmaceutics | Innovative Research Award

Published-on by Indian Scientist

Innovative Research Award

Meghraj Vivekanand Suryawanshi
Affiliation Savitribai Phule Pune University
Country India
Scopus ID 58037948200
Documents 48
Citations 104
h-index 5
Subject Area Pharmaceutics
Event Indian Scientist Awards
ORCID 0000-0003-3958-2813

Meghraj Vivekanand Suryawanshi

Savitribai Phule Pune University, India

Meghraj Vivekanand Suryawanshi has contributed to the field of Pharmaceutics through research activities reflected in indexed publications, citations, and measurable scholarly impact. His academic profile demonstrates sustained engagement in pharmaceutical sciences and related research domains, supporting scientific knowledge dissemination and interdisciplinary collaboration.[1][2]

Abstract

This article presents an academic overview of Meghraj Vivekanand Suryawanshi and his scholarly contributions within the field of Pharmaceutics. The profile highlights publication activity, citation performance, research engagement, and academic impact indicators documented through internationally recognized indexing platforms. The assessment considers research productivity, contribution to pharmaceutical sciences, and relevance to innovation-oriented scientific recognition programs.[1]

Keywords

Pharmaceutics, Drug Delivery Systems, Pharmaceutical Research, Scientific Innovation, Research Impact, Scholarly Publications, Citation Analysis, Academic Recognition, Pharmaceutical Sciences, Innovative Research Award.

Introduction

Research in pharmaceutics plays a fundamental role in improving therapeutic outcomes, formulation technologies, drug delivery mechanisms, and pharmaceutical manufacturing processes. Academic researchers contribute to the advancement of healthcare through experimental investigations, translational research, and dissemination of scientific findings. Meghraj Vivekanand Suryawanshi’s scholarly profile reflects active participation in these efforts through publication and citation records indexed in major academic databases.[1]

Research Profile

Meghraj Vivekanand Suryawanshi is affiliated with Savitribai Phule Pune University, a recognized institution engaged in higher education and scientific research. His documented scholarly profile includes research publications indexed in Scopus, demonstrating contributions to pharmaceutical sciences and related disciplines.[1]

  • Institutional Affiliation: Savitribai Phule Pune University.
  • Country of Research Activity: India.
  • Scopus Indexed Documents: 48.
  • Citation Count: 104.
  • h-index: 5.
  • Primary Subject Area: Pharmaceutics.

Research Contributions

The research contributions associated with this profile encompass pharmaceutical formulation studies, drug delivery approaches, evaluation methodologies, and related pharmaceutical investigations. Such work supports the broader objective of improving therapeutic effectiveness and scientific understanding within the pharmaceutical sector.[3]

  • Development and evaluation of pharmaceutical formulations.
  • Investigation of drug delivery technologies.
  • Research supporting pharmaceutical quality and efficacy assessment.
  • Contribution to peer-reviewed scientific literature.
  • Participation in collaborative and interdisciplinary research activities.

Publications

Publication activity serves as an important indicator of academic productivity. The available bibliometric profile demonstrates a record of peer-reviewed outputs that contribute to knowledge generation in pharmaceutical sciences and allied research areas.[1]

  1. Research articles indexed in international scientific databases.
  2. Studies related to pharmaceutical formulation and evaluation.
  3. Scientific communications supporting evidence-based pharmaceutical development.
  4. Collaborative publications contributing to interdisciplinary knowledge exchange.

Research Impact

Research impact may be evaluated through bibliometric indicators including publication volume, citation performance, and h-index metrics. With 48 indexed documents, 104 citations, and an h-index of 5, the profile demonstrates measurable scholarly visibility within the academic community.[1]

  • Evidence of sustained scholarly publication activity.
  • Research findings referenced by other investigators.
  • Contribution to scientific discourse within pharmaceutics.
  • Academic visibility reflected through citation metrics.

Award Suitability

The Innovative Research Award recognizes researchers whose scholarly activities contribute to scientific advancement and innovation. Based on the documented research profile, publication record, citation indicators, and engagement in pharmaceutical sciences, Meghraj Vivekanand Suryawanshi demonstrates attributes commonly associated with academic recognition programs emphasizing innovation, research productivity, and knowledge dissemination.[1][2]

Conclusion

Meghraj Vivekanand Suryawanshi’s academic profile reflects sustained participation in pharmaceutical research and scholarly publication. Through documented contributions in Pharmaceutics, indexed publications, citation performance, and measurable research indicators, the profile represents ongoing engagement with scientific inquiry and evidence-based knowledge development. These characteristics align with the objectives of professional research recognition initiatives such as the Innovative Research Award.[1]

References

  1. Scopus author details: Meghraj Vivekanand Suryawanshi, Author ID 58037948200. Scopus.https://www.scopus.com/authid/detail.uri?authorId=58037948200
  2. Medicinal and Nutritional Importance of Hypericum perforatum in Human Health.https://link.springer.com/chapter/10.1007/978-981-95-3620-7_13
  3. Neuroprotective efficacy of Nyctanthes arbor-tristis in a rotenone-induced rat model of Parkinson’s disease

    https://www.sciencedirect.com/science/article/abs/pii/S0378874126006781?via%3Dihub

Jon Jyoti Sahariah | Medicinal Chemistry | Research Excellence Award

Published-on by Indian Scientist

Research Excellence Award

Jon Jyoti Sahariah
Dibrugarh University, India

Jon Jyoti Sahariah
Affiliation Dibrugarh University
Country India
Scopus ID 57225212218
Documents 19
Citations 125
h-index 6
Subject Area Medicinal Chemistry
Event Indian Scientist Awards

Jon Jyoti Sahariah is an academic researcher affiliated with Dibrugarh University, India, whose scholarly activities are associated with medicinal chemistry, pharmaceutical sciences, drug delivery systems, and therapeutic development. His published research contributions demonstrate engagement with contemporary challenges in drug discovery, targeted therapeutics, and biomedical innovation. Through peer-reviewed publications, citation impact, and interdisciplinary collaborations, he has contributed to advancing scientific understanding within medicinal chemistry and related biomedical disciplines.[1]

Abstract

This article presents an academic overview of Jon Jyoti Sahariah and his scholarly contributions within medicinal chemistry and pharmaceutical research. The profile summarizes research interests, publication records, citation metrics, scientific influence, and relevance to recognition through the Research Excellence Award. The assessment is based on publicly available scholarly indicators and peer-reviewed academic outputs.[1]

Keywords

Medicinal Chemistry, Drug Discovery, Pharmaceutical Sciences, Targeted Drug Delivery, Cancer Therapeutics, Liposomal Formulations, Biomedical Research, Therapeutic Development, Scientific Publications, Research Excellence.

Introduction

Medicinal chemistry plays a critical role in the development of novel therapeutic agents and advanced healthcare solutions. Researchers working in this field contribute to the identification, optimization, and evaluation of biologically active compounds for the prevention and treatment of diseases. Jon Jyoti Sahariah’s academic activities align with these objectives through investigations focused on pharmaceutical formulations, drug delivery systems, and therapeutic innovations. His work reflects interdisciplinary collaboration across chemistry, pharmacy, and biomedical sciences.[2]

Research Profile

The scholarly profile of Jon Jyoti Sahariah demonstrates sustained participation in scientific research and publication. According to available bibliometric indicators, his research output includes nineteen indexed documents, 125 citations, and an h-index of six. These metrics indicate measurable academic visibility and engagement within the scientific community. His publications encompass medicinal chemistry, drug delivery technologies, cancer therapeutics, and pharmaceutical innovations.[1]

  • Affiliation with Dibrugarh University, India.
  • Research specialization in medicinal chemistry and pharmaceutical sciences.
  • Indexed publications in peer-reviewed journals.
  • Interdisciplinary collaboration involving drug discovery and therapeutic development.

Research Contributions

Jon Jyoti Sahariah has contributed to studies involving natural bioactive compounds, targeted cancer therapies, liposomal drug delivery systems, and pharmaceutical technologies. Several publications examine mechanisms for improving therapeutic efficacy while reducing adverse effects associated with conventional treatments. Research efforts in these domains contribute to ongoing developments in precision medicine and translational pharmaceutical science.[3]

  • Investigation of natural compounds with therapeutic potential.
  • Research on advanced liposomal drug delivery systems.
  • Contributions to targeted cancer therapy methodologies.
  • Participation in multidisciplinary biomedical research projects.

Publications

Selected scholarly works associated with Jon Jyoti Sahariah include publications addressing cancer chemotherapy, liposomal drug delivery, and medicinal chemistry innovations. Representative studies include highly cited articles focusing on natural bioactive compounds and targeted therapeutic approaches.[3]

  1. Cancer Chemotherapy via Natural Bioactive Compounds.
  2. Advancing Liposomal Doxorubicin for Targeted Cancer Therapy.
  3. Research involving pharmaceutical formulation and drug delivery technologies.
  4. Studies related to medicinal chemistry and therapeutic development.

Research Impact

Research impact can be assessed through publication output, citation frequency, collaborative scholarship, and relevance to scientific advancement. The citation record associated with Jon Jyoti Sahariah indicates that his work has been referenced by researchers in related fields, reflecting scholarly engagement and knowledge dissemination. Contributions to pharmaceutical sciences and medicinal chemistry support ongoing scientific dialogue regarding improved therapeutic interventions.[1]

Award Suitability

The Research Excellence Award recognizes researchers demonstrating meaningful scholarly contributions, scientific productivity, and academic influence. Based on available publication records, citation metrics, and participation in medicinal chemistry research, Jon Jyoti Sahariah exhibits characteristics consistent with the objectives of academic recognition programs. His work contributes to knowledge advancement in pharmaceutical and biomedical sciences while supporting innovation in therapeutic research.[1][4]

Conclusion

Jon Jyoti Sahariah has established a scholarly profile characterized by contributions to medicinal chemistry, drug delivery systems, and pharmaceutical sciences. Through peer-reviewed publications, citation impact, and collaborative scientific efforts, he has participated in research addressing significant healthcare and therapeutic challenges. His academic record supports consideration for professional recognition through the Research Excellence Award and reflects ongoing engagement with scientific advancement.[1]

References

  1. Scopus author details: Jon Jyoti Sahariah, Author ID 57225212218. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57225212218
  2. Cancer chemotherapy via natural bioactive compounds. https://www.benthamdirect.com/content/journals/cddt/10.2174/1570163819666220331095744
  3. From bench to bedside: Advancing liposomal doxorubicin for targeted cancer therapy. https://www.sciencedirect.com/science/article/pii/S2666845925000601
  4. Revolutionizing patient care: 3D printing for customized medical devices and therapeutics. https://link.springer.com/article/10.1007/s44174-025-00324-2

Gnana Ruba Priya Muthaiya | Medicinal Chemistry | Best Researcher Award

Published-on by Indian Scientist

Dr. Gnana Ruba Priya Muthaiya | Medicinal Chemistry | Best Researcher Award

Dayananda Sagar University, India

Dr. Gnana Ruba Priya Muthaiya is an accomplished pharmaceutical chemist and academician with advanced expertise in medicinal chemistry and drug design. Holding doctoral and postgraduate qualifications in pharmaceutical sciences, she has extensive experience in teaching, research, and mentoring across pharmacy disciplines. Her research focuses on computer-aided drug discovery, green synthesis, and anticancer therapeutics. With numerous peer-reviewed publications, patents, and scientific contributions, she has earned recognition for research excellence. Her work reflects a strong commitment to innovative drug development and impactful advancements in healthcare science.

Citation Metrics (Scopus)

70
50
30
10
0

Citations
60

Documents
1

h-index
1

Citations

Documents

h-index

Featured Publications


Artificial intelligence in screening: Models versus experiments


– Drug Discovery Today (Cited by 93 · Year: 2022)

Vidhya Bhusari | Pharmaceutical Sciences | Women Researcher Award

Published-on by Indian Scientist

Dr. Vidhya Bhusari | Pharmaceutical Sciences | Women Researcher Award

Chitkara College of Pharmacy, Chitkara University, India

Dr. Vidhya Kishore Bhusari is an accomplished pharmaceutical chemist with advanced training in pharmaceutical chemistry and extensive experience spanning academia and the pharmaceutical industry. She has contributed significantly to analytical method development, drug regulatory affairs, and quality assurance. Her research focuses on green analytical chemistry, HPTLC, HPLC, LC-MS techniques, stability-indicating methods, and QbD approaches. She is a recognized award recipient with impactful publications, patents, and scholarly books, contributing meaningfully to pharmaceutical education and research advancement.

Research Metrics (Scopus)

200
150
100
50
10
5
0

Citations
198

Documents
40

h-index
9

Citations

Documents

h-index

Featured Publications

Hardik Kumar | Pharmaceutical Sciences | Best Researcher Award

Published-on by Indian Scientist

Mr. Hardik Kumar | Pharmaceutical Sciences | Best Researcher Award

CT University,  India

Hardik Kumar is a pharmaceutical sciences academic and researcher specializing in pharmacy practice and clinical research. He holds advanced training up to doctoral coursework level, with postgraduate qualifications in pharmacy practice. His experience includes teaching, clinical exposure, pharmacovigilance activities, and academic coordination. His research interests span epilepsy, cardiometabolic disorders, infectious diseases, pharmacotherapy, drug safety, and quality-of-life assessment. He has authored multiple peer-reviewed publications, books, patents, and copyrights, received national-level awards, and actively contributes as a reviewer, speaker, and member of professional scientific bodies.

Citation Metrics (Scopus)

25
20
15
10
5
0

Citations
24

Documents
9

h-index
3

Citations

Documents

h-index

Featured Publications

Datta Pawde | Pharmaceutical Analysis | Best Researcher Award

Published-on by Indian Scientist

Dr. Datta Pawde | Pharmaceutical Analysis | Best Researcher Award

Department of Pharmaceutical Sciences,  India

Dr. Datta Maroti Pawde is an academic and researcher in Pharmaceutics, currently serving as an Assistant Professor in Pharmaceutical Sciences at a central university in India. He holds doctoral and postgraduate training from nationally reputed institutes and has teaching experience at a leading deemed university. His research interests focus on advanced drug delivery systems, formulation development, and pharmaceutical technology. He has received prestigious fellowships, international research recognition, and academic honors, reflecting his strong contribution to pharmaceutical education and research.

Citation Metrics (Scopus)

600
500
30
20
10
0

Citations
512

Documents
27

h-index
12

Citations

Documents

h-index

Featured Publications

Nirav Soni | Analytical Chemistry | Young Scientist Award

Published-on by Indian Scientist

Dr. Nirav Soni | Analytical Chemistry | Young Scientist Award

Gujarat Technological University | India

Dr. Nirav Rajendrakumar Soni is an accomplished pharmaceutical academic and researcher specializing in quality assurance, analytical and bioanalytical chemistry. He holds advanced qualifications in pharmacy and interdisciplinary domains, with extensive experience in teaching, research supervision, and laboratory management at a NAAC-accredited institution. His research focuses on chromatography-based impurity profiling, method development, validation, and pharmaceutical analysis. A prolific author, editor, and reviewer, he has received numerous national and international honors for research excellence, innovation, and academic leadership, contributing significantly to pharmaceutical education and research advancement.

Citation Metrics (Google Scholar)

50
40
30
20
5
0

Citations
47

h-index
4

i10index
0

Citations

h-index

i10-index

Featured Publications


Improve GC separations with derivatization for selective response and detection in novel matrices


– Journal of Environment and Life Sciences 1 (1), 1–12 | Cited by: 9 | 2016


To study the herbalism of thyme leaves


– International Journal of Pharmacy and Industrial Research 2 (3), 252–258 | Cited by: 8 | 2012


Current Management on PCOS (Polycystic Ovary Syndrome) / Stein-Leventhal Syndrome


– Investigations in Gynecology Research & Women’s Health | Cited by: 7 | 2017


A new looming of Zika virus


– Asian Pacific Journal of Reproduction 5 (3), 179–181 | Cited by: 4 | 2016
All publication titles open direct Google Scholar search results for maximum visibility and accessibility.

Rahul Kumar | Pharmaceutical Chemistry | Young Scientist Award

Published-on by Indian Scientist

Mr. Rahul Kumar | Pharmaceutical Chemistry | Young Scientist Award

Vidya University | India

Rahul Kumar is an Assistant Professor in Pharmacy with expertise in Computer-Aided Drug Design and Pharmaceutical Chemistry. He holds professional training in pharmaceutical sciences and contributes to teaching and research in drug discovery, molecular modeling, and computational chemistry. His research focuses on CADD, medicinal chemistry, biosensors, and AI-driven approaches in healthcare. He has authored peer-reviewed publications, book chapters, and patents, and has received national-level research and innovation awards, reflecting a strong commitment to academic excellence and translational research.

Citation Metrics (Scopus)

20
15
10
5
0

Citations
11

h-index
1

Documents
1

Citations

h-index

Documents

Featured Publications

Citation counts are indicative and may vary across databases; all links redirect to open Google Scholar search results.

Sachin Dhawale | Medicinal Chemistry | Best Researcher Award

Published-on by Indian Scientist

Assoc. Prof. Dr. Sachin Dhawale | Medicinal Chemistry | Best Researcher Award

Shreeyash Institute of Pharmaceutical Education and Research | India

Dr. Sachin Ashok Dhawale is a dedicated researcher in medicinal chemistry and pharmaceutical sciences, recognized for his contributions to drug design, molecular modeling, and synthetic chemistry. With a strong academic foundation including a PhD in Pharmacy, M.Pharm in Pharmaceutical Chemistry, and a B.Pharm degree, he has built extensive experience across academic and research environments, serving in teaching positions and contributing to funded research projects as a JRF and SRF under national scientific bodies. His scientific impact is reflected in 136 citations, an h-index of 6, and an i10-index of 4, supported by more than 25 Scopus-indexed publications, several as first or corresponding author, and cumulative impact exceeding 50. His research spans anticancer agents, antimicrobial molecules, molecular docking, natural product-based therapeutics, ADMET studies, and computational chemistry approaches. He has guided multiple undergraduate and postgraduate research projects, presented papers at national and international conferences, and published a specialized book on computer-aided drug design. His work has earned several recognitions including first-prize awards at competitive scientific events and fellowship support from national and state agencies. With expertise in advanced cheminformatics tools and synthetic techniques, he continues to contribute to innovative therapeutic discovery aimed at improving human health.

Profile: Google Scholar | Orcid

Featured Publications

Gandla, K., Islam, F., Zehravi, M., Karunakaran, A., Sharma, I., Haque, M. A., … Dhawale, S. A. (2023). Natural polymers as potential P-glycoprotein inhibitors: Pre-ADMET profile and computational analysis as a proof of concept to fight multidrug resistance in cancer. Heliyon, 9(9).

Singu, P. S., Kanugala, S., Dhawale, S. A., Kumar, C. G., & Kumbhare, R. M. (2020). Synthesis and pharmacological evaluation of some amide functionalized 1H-benzo[d]imidazole-2-thiol derivatives as antimicrobial agents. ChemistrySelect, 5(1), 117–123.

Dube, P. N., Sakle, N. S., Dhawale, S. A., More, S. A., & Mokale, S. N. (2019). Synthesis, biological investigation and docking study of novel chromen derivatives as anti-cancer agents. Anti-Cancer Agents in Medicinal Chemistry, 13.

Gawai, A. A., Kharat, A. R., Chorge, S. S., & Dhawale, S. A. (2023). Green synthesis of silver nanoparticles mediated Azadirachta indica extract and study of their characterization, molecular docking, and antibacterial activity. Journal of Molecular Recognition, 36(10), e3051.

Suryawanshi, R. M., Shimpi, R. B., Muralidharan, V., Nemade, L. S., Gurugubelli, S., … Dhawale, S. A. (2025). ADME, toxicity, molecular docking, molecular dynamics, glucokinase activation, DPP-IV, α-amylase, and α-glucosidase inhibition assays of mangiferin and friedelin for antidiabetic potential. Chemistry & Biodiversity, 22(5), e202402738.